as on October 22, 2025 at 1:29 am IST
Day's Low
Day's High
0.28%
Downside
3.90%
Upside
52 Week's Low
52 Week's High
64.62%
Downside
39.28%
Upside
Check Corvus Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$556.6M
EPS (TTM)
-0.135
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-35.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
8645100.00%
Compare market cap, revenue, PE, and other key metrics of Corvus Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $556.6M | 80% | NA | 0.00% | |
BUY | $34.9B | 342.12% | -16.34 | -259.82% | |
BUY | $64.4B | 252.94% | -505.15 | -12.96% | |
BUY | $107.5B | 102.91% | 29.68 | 31.86% | |
BUY | $61.3B | 0.63% | 14.58 | 31.37% |
The Corvus Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Corvus Pharmaceuticals Inc investment value today
Current value as on today
₹97,453
Returns
Returns from Corvus Pharmaceuticals Inc Stock
Dollar Returns*
₹4,808 (+4.81%)
Based on 10 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Corvus Pharmaceuticals Inc. Average target price of $15
Get share price movements and forecasts by analysts on Corvus Pharmaceuticals Inc.
What analysts predicted
52.13%UPSIDE
Target Price
$15
Current Price
$7.18
Analyzed by
10 Analysts
Target
$15.00
Corvus Pharmaceuticals Inc target price $15, a slight upside of 52.13% compared to current price of $7.18. According to 10 analysts rating.
Search interest for Corvus Pharmaceuticals Inc Stock has increased by 46% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:46% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 02 October
Fri, 01:31 AM
-David Moore appointed to Corvus Pharmaceuticals' Board of Directors, bringing extensive industry experience.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, CRVS stock has moved up by 19.2%
Best in 3 Years
In the last 3 years, CRVS has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.9% return, outperforming this stock by 67.0%
Organisation | Corvus Pharmaceuticals Inc |
Headquarters | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Industry | Health Technology |
CEO | Dr. Richard A. Miller M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Leiv Lea | Chief Financial Officer |
Dr. William Benton Jones Ph.D. | Senior Vice President of Pharmaceutical Development |
Mr. Jeffrey S. Arcara | Senior VP & Chief Business Officer |
Dr. Richard A. Miller M.D. | Co-Founder, President, CEO & Chairman of the Board |
Dr. Peter A. Thompson FACP, M.D. | Co-Founder & Independent Director |
Corvus Pharmaceuticals Inc share price today is $7.18 as on at the close of the market. Corvus Pharmaceuticals Inc share today touched a day high of $7.46 and a low of $7.16.
Corvus Pharmaceuticals Inc share touched a 52 week high of $10 on and a 52 week low of $2.54 on . Corvus Pharmaceuticals Inc stock price today i.e. is closed at $7.18,which is 28.20% down from its 52 week high and 182.68% up from its 52 week low.
Corvus Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Corvus Pharmaceuticals Inc (CRVS) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Corvus Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Corvus Pharmaceuticals Inc share’s latest price of $7.18 as on October 22, 2025 at 1:29 am IST, you will get 1.3928 shares of Corvus Pharmaceuticals Inc. Learn more about
fractional shares .
Corvus Pharmaceuticals Inc stock has given 80% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?